Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy
NCT05141279 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2021-12-02
Summary
The aim of this work to evaluate the accuracy of contrast enhanced spectral mamography in predicting the response to NAC and assessment of residual disease in breast cancer patients
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-01
- Primary Completion
- 2023-12-01
- Completion
- 2024-01-01
More Related Trials
-
MRI and Early Decision-making in Chemotherapy for Breast Cancer
NCT02449824 ·Status: COMPLETED
-
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 ·Status: RECRUITING ·Phase: NA
-
Diffusion Magnetic Resonance Imaging in Mamographically Detected Asymmetric Densities
NCT03696147 ·Status: UNKNOWN
-
Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
NCT03580837 ·Status: UNKNOWN
-
What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?
NCT03501394 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT
NCT03468374 ·Status: UNKNOWN ·Phase: NA
-
The Application Value of Spectral CT in the Accurate Staging of Breast Cancer
NCT06977412 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System
NCT02690805 ·Status: COMPLETED
-
The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802 ·Status: COMPLETED
-
Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery
NCT00233974 ·Status: COMPLETED ·Phase: PHASE2
-
Abbreviated Breast MRI in Cancer Detection
NCT03870659 ·Status: COMPLETED
-
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
NCT03568448 ·Status: ACTIVE_NOT_RECRUITING
-
Functional MRI in Predicting Response to Chemotherapy
NCT03969524 ·Status: UNKNOWN
-
Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer
NCT05307757 ·Status: RECRUITING
-
Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer
NCT03289195 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging
NCT04767659 ·Status: RECRUITING ·Phase: NA
-
Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test
NCT04264468 ·Status: UNKNOWN
-
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics
NCT05826197 ·Status: UNKNOWN
-
Surveillance Imaging Modalities for Breast Cancer Assessment
NCT02212834 ·Status: COMPLETED
-
Shear Wave Elastography Assessment of Neoadjuvant Chemotherapy Response in Patients With Invasive Breast Cancer
NCT05068999 ·Status: UNKNOWN
-
Angiomammography and Neoadjuvant Chemotherapy
NCT05402930 ·Status: COMPLETED ·Phase: NA
-
Demographic , Clinicopathological Characteristics and Survival of Breast Cancer
NCT04316247 ·Status: UNKNOWN
-
Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
NCT03881384 ·Status: UNKNOWN
-
Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer
NCT03176979 ·Status: COMPLETED ·Phase: NA